October 10, 2020
Coronavirus: I'm part of a COVID-19 vaccine trial in New Jersey
I volunteered for a COVID-19 vaccine trial in New Jersey. Here's what it's been like since the shot.
The day of my appointment, I read and signed the 22-page consent form. Balani took my medical history, gave me a physical and swabbed me to see if I had an active COVID-19 infection. A nurse took my vital signs and eight vials of blood. I downloaded the app and learned how to use it.
This is called a double-blind study because both the researchers and the participants are blind to what was inside that syringe.
I admit, I have a hunch. But I won’t share it, in case the team monitoring me reads this.
For seven days after my injection, I took my temperature each evening, measured the size of the mosquito-bite-sized bump on my arm as it faded away, and noted that at first my arm hurt a little, but “not enough to affect daily activities.” I recorded this and other information — including my lack of headaches, fatigue, muscle aches and nausea — on a secure phone app that sends the data to Moderna.
A nurse prepares a shot in July as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc.
To answer one question I get a lot: No one will deliberately expose me to the virus as part of this study.
Dramatically higher risk is not part of the deal. I have no plans to stroll unprotected through an intensive care unit for COVID patients. To be honest, I don’t even plan to dine indoors at a restaurant.
That caution, which experts say is shared by other trial volunteers, may actually slow the research; the faster that cases accumulate, the faster experts can see whether the vaccine works.
Unfortunately for research science, people who volunteer for studies like this tend to be better educated and more health-oriented.
They are therefore more likely to protect themselves from COVID-19, which means it will be a while before a sufficient number of infections piles up.
Not since the polio epidemic has the public been more fixated on the race for a vaccine. Who will get the first batches? How it will be distributed? How effective will it be? How will the public accept it?
All these questions remain unanswered. But I feel like I’m part of history now.
I’ll let you know what happens.